tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sarepta Therapeutics’ Long-term Study on SRP-9001: A Boost for Investor Confidence?
PremiumCompany AnnouncementsSarepta Therapeutics’ Long-term Study on SRP-9001: A Boost for Investor Confidence?
4d ago
SRPT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
SRPT Upcoming Earnings Report: What to Expect?
4d ago
Sarepta price target raised to $18 from $16 at BofA
Premium
The Fly
Sarepta price target raised to $18 from $16 at BofA
9d ago
Iron Mountain, Lennar, Sarepta, Paycom, Guardant: Trending by Analysts
PremiumWeekend UpdatesIron Mountain, Lennar, Sarepta, Paycom, Guardant: Trending by Analysts
1M ago
Pfizer to acquire Metsera, Oracle names new CEOs: Morning Buzz
Premium
The Fly
Pfizer to acquire Metsera, Oracle names new CEOs: Morning Buzz
1M ago
Sarepta Therapeutics: Positioned for Growth Amidst Elevidys Uptake and Portfolio Diversification
Premium
Ratings
Sarepta Therapeutics: Positioned for Growth Amidst Elevidys Uptake and Portfolio Diversification
1M ago
Sarepta Therapeutics Completes Convertible Notes Exchange
PremiumCompany AnnouncementsSarepta Therapeutics Completes Convertible Notes Exchange
2M ago
Sarepta down 10% on new adverse event report, says Deutsche Bank
Premium
The Fly
Sarepta down 10% on new adverse event report, says Deutsche Bank
2M ago
Elanco to replace Sarepta in S&P 400 at open on 9/2
Premium
The Fly
Elanco to replace Sarepta in S&P 400 at open on 9/2
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100